𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy

✍ Scribed by Andrew Biggin; Katherine Holman; Maggie Brett; Bruce Bennetts; Lesley Adès


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
49 KB
Volume
23
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1). Recent studies have illustrated the variability in disease severity and clinical manifestations of MFS. Useful genotype-phenotype correlations have been slow to emerge. We screened 57 unrelated patients with MFS or a Marfan-like phenotype using a combination of SSCP and/or DHPLC. We detected 49 different FBN1 mutations, 30 (62%) of which were novel. The mutations comprised 38 substitutions (78%), 10 deletions (20%), and one duplication (2%). There were 28 missense (57%), nine frameshift (18%), eight splice site (16%), and four nonsense mutations (8%). Genotypephenotype analysis revealed that patients with an identified FBN1 mutation were more likely to have ectopia lentis and cardiovascular complications compared to those without an identifiable mutation (relative risks of 4.6 and 1.9, respectively). Ectopia lentis was also found to be more prevalent in patients whose mutations involved a cysteine substitution (relative risk 1.6) and less prevalent in those with premature termination mutations (relative risk 0.4). In our hands, we achieved 93% mutation detection for DHPLC analysis of patients who fulfilled the Ghent criteria. Further analysis of detailed clinical information and mutation data may help to anticipate the clinical consequences of specific FBN1 mutations.


📜 SIMILAR VOLUMES


Mutations of FBN1 and genotype–phenotype
✍ Peter N. Robinson; Patrick Booms; Stefanie Katzke; Markus Ladewig; Luitgard Neum 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The Marfan syndrome (MFS) is a pleiotropic, autosomal dominant disorder of connective tissue with highly variable clinical manifestations including aortic dilatation and dissection, ectopia lentis, and a series of skeletal anomalies. Mutations in the gene for fibrillin-1 (FBN1) cause MFS, and at lea

Detection of six novel FBN1 mutations in
✍ Paolo Comeglio; Alison L. Evans; Glen W. Brice; Anne H. Child 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Marfan syndrome (MFS), an autosomal dominant disorder of the extracellular matrix, is due to mutations in fibrillin-1 (FBN1) gene. Investigations carried out in the last decade, unveiled the unpredictability of the site of the mutation, which could be anywhere in the gene. FBN1 mutations have been r

Identification of 9 novel FBN1 mutations
✍ Alice Abd El-Aleem; Matthias Karck; Axel Haverich; Jörg Schmidtke; Mine Arslan-K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 20 KB 👁 2 views

We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by

The importance of mutation detection in
✍ Paolo Comeglio; Philip Johnson; Gavin Arno; Glen Brice; Alison Evans; José Arago 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

Mutations in the FBN1 gene have been characterised in patients affected by Marfan syndrome and Marfan-related disorders. Starting with genomic DNA, we analysed the FBN1 gene using PCR, SSCP and/or dHPLC analysis, and automatic sequencing of abnormal bands/peaks, in a consecutive series of 508 patien

Erratum: Detection of six novel FBN1 mut
✍ Paolo Comeglio; Alison L. Evans; Glen W. Brice; Anne H. Child 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Marfan syndrome (MFS), an autosomal dominant disorder of the extracellular matrix, is due to mutations in fibrillin-1 (FBN1) gene. Investigations carried out in the last decade, unveiled the unpredictability of the site of the mutation, which could be anywhere in the gene. FBN1 mutations have been r